Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss

Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss

Anne-Priscille Trouvin, Vincent GoëbDepartment of Rheumatology, Rouen University Hospital, Rouen, FranceAbstract: Bone remodeling requires a precise balance between resorption and formation. It is a complex process that involves numerous factors: hormones, growth factors, vitamins, and cyto...

Full description

Bibliographic Details
Main Authors: Anne-Priscille Trouvin, Vincent Goëb
Format: Article
Language:English
Published: Dove Medical Press 2010-11-01
Series:Clinical Interventions in Aging
Subjects:
Osteoprotegerin
RANK
RANKL
Denosumab
Strontium ranelate
Osteoporosis
Online Access:https://www.dovepress.com/receptor-activator-of-nuclear-factor-kappab-ligand-and-osteoprotegerin-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/receptor-activator-of-nuclear-factor-kappab-ligand-and-osteoprotegerin-peer-reviewed-article-CIA

Similar Items